Rinella ME - Search Results

1

A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.

Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Labriola D, Moussa SE, Neff GW, Rinella ME, Anstee QM, Abdelmalek MF, Younossi Z, Baum SJ, Francque S, Charlton MR, Newsome PN, Lanthier N, Schiefke I, Mangia A, Pericàs JM, Patil R, Sanyal AJ, Noureddin M, Bansal MB, Alkhouri N, Castera L, Rudraraju M, Ratziu V; MAESTRO-NASH Investigators. Harrison SA, et al. Among authors: rinella me. N Engl J Med. 2024 Feb 8;390(6):497-509. doi: 10.1056/NEJMoa2309000. N Engl J Med. 2024. PMID: 38324483 Clinical Trial.

2

Intensive management of hepatic failure.

Rinella ME, Sanyal A. Rinella ME, et al. Semin Respir Crit Care Med. 2006 Jun;27(3):241-61. doi: 10.1055/s-2006-945528. Semin Respir Crit Care Med. 2006. PMID: 16791758 Review.

3

Controversies in the Diagnosis and Management of NAFLD and NASH.

Rinella ME, Loomba R, Caldwell SH, Kowdley K, Charlton M, Tetri B, Harrison SA. Rinella ME, et al. Gastroenterol Hepatol (N Y). 2014 Apr;10(4):219-27. Gastroenterol Hepatol (N Y). 2014. PMID: 24976805 Free PMC article.

4

NAFLD in 2014: Genetics, diagnostics and therapeutic advances in NAFLD.

Rinella ME, Sanyal AJ. Rinella ME, et al. Nat Rev Gastroenterol Hepatol. 2015 Feb;12(2):65-6. doi: 10.1038/nrgastro.2014.232. Epub 2015 Jan 6. Nat Rev Gastroenterol Hepatol. 2015. PMID: 25560844 Free PMC article. Review.

5

Nonalcoholic Fatty liver disease, diabetes, obesity, and hepatocellular carcinoma.

Noureddin M, Rinella ME. Noureddin M, et al. Among authors: rinella me. Clin Liver Dis. 2015 May;19(2):361-79. doi: 10.1016/j.cld.2015.01.012. Epub 2015 Mar 12. Clin Liver Dis. 2015. PMID: 25921668 Free PMC article. Review.

6

Practice patterns in NAFLD and NASH: real life differs from published guidelines.

Rinella ME, Lominadze Z, Loomba R, Charlton M, Neuschwander-Tetri BA, Caldwell SH, Kowdley K, Harrison SA. Rinella ME, et al. Therap Adv Gastroenterol. 2016 Jan;9(1):4-12. doi: 10.1177/1756283X15611581. Therap Adv Gastroenterol. 2016. PMID: 26770262 Free PMC article.

7

Management of NAFLD: a stage-based approach.

Rinella ME, Sanyal AJ. Rinella ME, et al. Nat Rev Gastroenterol Hepatol. 2016 Apr;13(4):196-205. doi: 10.1038/nrgastro.2016.3. Epub 2016 Feb 24. Nat Rev Gastroenterol Hepatol. 2016. PMID: 26907882 Review.

8

The globalization of nonalcoholic fatty liver disease: Prevalence and impact on world health.

Rinella M, Charlton M. Rinella M, et al. Hepatology. 2016 Jul;64(1):19-22. doi: 10.1002/hep.28524. Epub 2016 Apr 4. Hepatology. 2016. PMID: 26926530 No abstract available.

9

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.

Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ. Chalasani N, et al. Hepatology. 2018 Jan;67(1):328-357. doi: 10.1002/hep.29367. Epub 2017 Sep 29. Hepatology. 2018. PMID: 28714183 Review. No abstract available.

10

Everolimus Is Associated With Less Weight Gain Than Tacrolimus 2 Years After Liver Transplantation: Results of a Randomized Multicenter Study.

Charlton M, Rinella M, Patel D, McCague K, Heimbach J, Watt K. Charlton M, et al. Transplantation. 2017 Dec;101(12):2873-2882. doi: 10.1097/TP.0000000000001913. Transplantation. 2017. PMID: 28817434 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters